Novel methods in diagnosis of endometriosis in future

In: International Journal of Reproduction, Contraception, Obstetrics and Gynecology · 2022 · vol. 11(6) , pp. 1824 · doi:10.18203/2320-1770.ijrcog20221472 · W4281721662
article OA: diamond CC0 ⤵ 2 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-07

This paper reviews emerging non-invasive diagnostic methods for endometriosis, including imaging, biomarkers like miRNAs and growth factors, and mitochondrial DNA variations, to overcome diagnostic delays associated with surgical confirmation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07

This paper is a narrative overview of future non-invasive diagnostic approaches for endometriosis, focusing on imaging modalities (USG, CT, MRI) and a range of candidate blood or tissue biomarkers. It reports that biomarkers including inflammatory markers (e.g., IL-6, IL-8, Hs-CRP, TNF-alpha), tumor markers (e.g., CA-125 and related glycoproteins), growth factors and immunologic markers (e.g., activin/follistatin, VEGF, NK-cell related markers), circulating endometrial cells, miRNAs (often with links to altered vaginal microbiome), and mitochondrial DNA variation have all been proposed to reduce diagnostic delays. A key limitation noted is that the evidence is presented broadly across multiple marker classes rather than as a single standardized diagnostic test strategy, and the clinical gap of delayed diagnosis up to about 7 years is emphasized. This paper is centrally about endometriosis — it synthesizes emerging non-invasive diagnostic methods and biomarker categories aimed at earlier endometriosis confirmation.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Endometriosis causes severe pain and infertility affecting quality of life. According to ASRM it is a chronic inflammatory disease that requires life-long management plan and surgery has to be restricted only once in the life time of the patient. Earlier, the diagnosis of endometriosis was confirmed by surgical method and histo-pathological examination. There is often a diagnostic delay up to 7 years or even beyond, which will affect the patients getting earlier treatment. Recently, lot of non-invasive techniques for diagnosis of endometriosis have come into vogue so that, treatment can be planned without surgical diagnosis. Apart from imaging through USG, CT or MRI, earlier lesions can be picked up by biomarkers like IL-6, IL-8, CA 125, HE4, neutrophil-lymphocytic ratio, Hs-CRP, Tumour necrosis alpha and mi RNA, neural elements in endometrium, glyco-proteins like CA-125, CA-19.9, CA-15.3, CA-73, AFP and CEA. Urocortin, activin and follistatin are growth factors and VEGF, TNF-alpha, NK cells, i-SCAM-I, MCP-1 are immunologic markers for diagnosis of endometriosis. Circulating endometrial cells are also present in the peripheral blood of patients. miRNA in endometriosis is found to be a potential biomarker in the recent years and also associated with altered vaginal microbiome. There has been up-regulation and down-regulation of certain miRNAs in endometriosis patients. In patients with symptoms of endometriosis, miRNA study in peripheral blood can be used as a biomarker for confirmation of diagnosis. There is a strong association between mitochondrial DNA variation and endometriosis which is found to be rational biomarkers.

My notes (saved in your browser only)

Condition tags

endometriosisinfertility

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (36)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK